These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 29372251)
1. Temporal Expression of Genes in Biofilm-Forming Ocular Candida albicans Isolated From Patients With Keratitis and Orbital Cellulitis. Ranjith K; Kalyana Chakravarthy S; Adicherla H; Sharma S; Shivaji S Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):528-538. PubMed ID: 29372251 [TBL] [Abstract][Full Text] [Related]
2. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms. Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303 [TBL] [Abstract][Full Text] [Related]
3. Candida Species From Eye Infections: Drug Susceptibility, Virulence Factors, and Molecular Characterization. Ranjith K; Sontam B; Sharma S; Joseph J; Chathoth KN; Sama KC; Murthy SI; Shivaji S Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4201-4209. PubMed ID: 28837732 [TBL] [Abstract][Full Text] [Related]
4. The Activity of Fungichromin against the Formation of Candida albicans Biofilm. An D; Wang X; Li J; Jiang S; Ma X; Zhang H; Shi H; Sun H; Ye L; Li J Biol Pharm Bull; 2016 Dec; 39(12):1948-1954. PubMed ID: 27615430 [TBL] [Abstract][Full Text] [Related]
5. Development of Lee HS; Kim Y J Microbiol Biotechnol; 2018 Mar; 28(3):482-490. PubMed ID: 29316739 [No Abstract] [Full Text] [Related]
6. Relative Abundances of Candida albicans and Candida glabrata in Olson ML; Jayaraman A; Kao KC Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422 [No Abstract] [Full Text] [Related]
7. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms. Jia W; Zhang H; Li C; Li G; Liu X; Wei J BMC Microbiol; 2016 Jun; 16(1):113. PubMed ID: 27316338 [TBL] [Abstract][Full Text] [Related]
8. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility. Zhang X; Sun X; Wang Z; Zhang Y; Hou W Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7774-8. PubMed ID: 23099491 [TBL] [Abstract][Full Text] [Related]
9. Chemical composition and antifungal activity of Satureja hortensis L. essentiall oil against planktonic and biofilm growth of Candida albicans isolates from buccal lesions of HIV(+) individuals. Sharifzadeh A; Khosravi AR; Ahmadian S Microb Pathog; 2016 Jul; 96():1-9. PubMed ID: 27126187 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth. Haque F; Alfatah M; Ganesan K; Bhattacharyya MS Sci Rep; 2016 Mar; 6():23575. PubMed ID: 27030404 [TBL] [Abstract][Full Text] [Related]
12. Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis? Brilhante RSN; Bittencourt PV; de Souza Collares Castelo-Branco D; de Melo Guedes GM; de Oliveira JS; Alencar LP; de Aguiar Cordeiro R; Pinheiro M; Nogueira-Filho EF; de Aquino Pereira-Neto W; Sidrim JJC; Rocha MFG Vet Ophthalmol; 2017 Nov; 20(6):539-546. PubMed ID: 28417524 [TBL] [Abstract][Full Text] [Related]
13. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans. Sun L; Liao K; Wang D PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475 [TBL] [Abstract][Full Text] [Related]
14. Expression of SAP5 and SAP9 in Candida albicans biofilms: comparison of bloodstream isolates with isolates from other sources. Joo MY; Shin JH; Jang HC; Song ES; Kee SJ; Shin MG; Suh SP; Ryang DW Med Mycol; 2013 Nov; 51(8):892-6. PubMed ID: 23971863 [TBL] [Abstract][Full Text] [Related]
15. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole. Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475 [TBL] [Abstract][Full Text] [Related]
16. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. Chandra J; Kuhn DM; Mukherjee PK; Hoyer LL; McCormick T; Ghannoum MA J Bacteriol; 2001 Sep; 183(18):5385-94. PubMed ID: 11514524 [TBL] [Abstract][Full Text] [Related]
17. Utilising polyphenols for the clinical management of Candida albicans biofilms. Shahzad M; Sherry L; Rajendran R; Edwards CA; Combet E; Ramage G Int J Antimicrob Agents; 2014 Sep; 44(3):269-73. PubMed ID: 25104135 [TBL] [Abstract][Full Text] [Related]
18. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis. Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477 [TBL] [Abstract][Full Text] [Related]
19. Effects of lactoferricin B against keratitis-associated fungal biofilms. Sengupta J; Saha S; Khetan A; Sarkar SK; Mandal SM J Infect Chemother; 2012 Oct; 18(5):698-703. PubMed ID: 22410856 [TBL] [Abstract][Full Text] [Related]